Armata PharmaceuticalsARMP
13F holders, Q2 2025 (June 30)29holders +3
5new positions
2sold out
1famous investor
$1.90avg. 13F price*
At the end of Q2 2025, 29 institutions reported holding Armata Pharmaceuticals Inc. (ARMP) in their 13F filings, up 3 from Q1 2025. 5 opened new positions and 2 sold out. The largest holders were Vanguard Group Inc. ($494K), Geode Capital Management, LLC ($199K) and Edgewood Management LLC ($190K). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Armata Pharmaceuticals Inc.
- CUSIP
- 04216R102
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 5 | $86K |
| Exits | 2 | $70K |
All 13F filers, Q1 2025 → Q2 2025: 48,321 shares bought and 54,875 shares sold, net −6,554 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 29 holders
| Vanguard Group Inc. | 0.00% | No change | 260,073 | $494K |
| Geode Capital Management, LLC | 0.00% | Reduce -1.2% | 104,546 | $199K |
| Edgewood Management LLC | 0.00% | No change | 100,000 | $190K |
| Bridgeway Capital Management, LLC | 0.00% | No change | 44,682 | $85K |
| State Street Corp. | 0.00% | No change | 40,300 | $77K |
| Renaissance Technologies | 0.00% | Add +0.8% | 38,896 | $74K |
| SeaCrest Wealth Management, LLC | 0.01% | No change | 34,954 | $66K |
| Grey Ledge Advisors, LLC | 0.01% | New | 30,000 | $57K |
| BlackRock, Inc. | 0.00% | Add +11.8% | 25,918 | $49K |
| Northern Trust Corp. | 0.00% | No change | 19,273 | $37K |
| Captrust Financial Advisors | 0.00% | No change | 13,140 | $25K |
| Two Sigma Securities, LLC | 0.00% | New | 13,104 | $25K |
| Group One Trading LLC | 0.00% | Reduce -37.5% | 3,000 | $6K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -50.9% | 1,705 | $3K |
| Cornerstone National Bank & Trust Co | 0.00% | No change | 1,428 | $3K |
| Cwm, LLC | 0.00% | New | 1,000 | $2K |
| Raymond James Financial Inc. | 0.00% | New | 1,000 | $2K |
| Trifecta Capital Advisors, LLC | 0.00% | No change | 714 | $1K |
| Northwestern Mutual Wealth Management Co. | 0.00% | No change | 571 | $1K |
| Osaic Holdings, Inc. | 0.00% | Add +28.0% | 457 | $868 |
| Morgan Stanley | 0.00% | No change | 109 | $207 |
| Bank of America Corp. | 0.00% | Add +10.8% | 103 | $195 |
| Salem Investment Counselors Inc. | 0.00% | No change | 100 | $190 |
| Team Financial Group, LLC | 0.00% | New | 71 | $135 |
| MAI Capital Management | 0.00% | No change | 71 | $135 |
| JPMorgan Chase & Co. | 0.00% | Add +9.1% | 24 | $46 |
| SBI Securities Co., Ltd. | 0.00% | No change | 3 | $6 |
| UBS Group AG | 0.00% | Reduce -99.9% | 1 | $2 |
| Wells Fargo & Company | 0.00% | No change | 1 | $1 |
"% of holder's portfolio" is ARMP's weight in each manager's 13F, not the share of Armata Pharmaceuticals Inc. the manager owns.